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Mechanisms of Zika Virus Infection and Neuropathogenesis
David Olagnier,1,* Michela Muscolini,2,* Carolyn B. Coyne,3 Michael S. Diamond,4–6 and John Hiscott2
A spotlight has been focused on the mosquito-borne Zika virus (ZIKV) because of its epidemic outbreak in
Brazil and Latin America, as well as the severe neurological manifestations of microcephaly and Guillain–Barre´
syndrome associated with infection. In this review, we discuss the recent literature on ZIKV-host interactions,
including new mechanistic insight concerning the basis of ZIKV-induced neuropathogenesis.
Introduction
Z ika virus (ZIKV) was originally isolated from an in-fected monkey in the Zika forest of Uganda in 1947 (Dick
and Haddow, 1952). For decades, transmission of this arbo-
virus to humans via the bite of the Aedes aegypti mosquito
was thought to cause a mild and self-limiting febrile syn-
drome, with most (*80%) infections being clinically inap-
parent. This perception has changed with epidemic outbreaks
in Yap Island in 2007, French Polynesia in 2013, and in Brazil
and other Latin American countries in 2015–2016. The
number of ZIKV infections has exploded and, with it, a causal
association of microcephaly and other congenital malforma-
tions in fetuses and newborns of ZIKV-infected mothers
(Brasil et al., 2016a), as well as Guillain–Barre´ syndrome
(Brasil et al., 2016b; Cao-Lormeau et al., 2016; Watrin et al.,
2016) and meningoencephalitis (Carteaux et al., 2016).
New modes of transmission, including in utero and sexual
transmission, as well as the presence of ZIKV in breast milk,
have been observed. ZIKV is now an emerging pathogen that
poses an imminent global threat (Brasil et al., 2016a; Broutet
et al., 2016; Calvet et al., 2016; Dupont-Rouzeyrol et al.,
2016; Hills et al., 2016; Sarno et al., 2016). In this review, we
summarize the most recent observations on the biology, tro-
pism, and neuropathogenesis associated with ZIKV.
Virus Structure
ZIKV belongs to the Flavivirus genus of the Flaviviridae
family, which includes other human pathogens such as dengue,
West Nile, yellow fever, tick-borne encephalitis, and Japanese
encephalitis viruses. ZIKV is a 50 nm spherical virion that
comprised three structural proteins (capsid [C], premembrane/
membrane [prM/M], and envelope [E]), a lipid envelope, and a
10.7 kb capped RNA of positive polarity. The E protein is a
class II viral membrane fusion protein that has an elongated
three-domain (domains [D] I–III) structure (Dai et al., 2016). E
protein directs several critical steps of the viral life cycle, in-
cluding engagement with cellular attachment and entry factors,
membrane fusion, and virus assembly. Recent high-resolution
cryoelectron microscopy of intact ZIKV virions was reported
(Kostyuchenko et al., 2016; Sirohi et al., 2016). The ZIKV
structure is similar to other flavivirus structures, except for
*10 amino acids that surround an N-linked glycosylation
site in E-DI. The carbohydrate moiety associated with this
residue has been speculated to contribute to an attachment
site for the virus to host cells. As this region varies among
flaviviruses, it could influence the unique aspects of ZIKV
transmission and disease (Sirohi et al., 2016).
ZIKV is believed to form only one serotype (Tappe et al.,
2015) with two main ZIKV lineages, African and Asian
(Haddow et al., 2012; Faye et al., 2014). Wang et al. (2016)
recently completed detailed phylogenetic and genetic ana-
lyses, as well as targeted structural modeling on all known
full-length open reading frames of ZIKV. This study showed
that ZIKV strains in the recent human outbreak evolved from
the Asian lineage, and that all human strains identified in the
2015–2016 epidemic appear closely related to the H/PF/2013
strain isolated in French Polynesia in 2013 (Wang et al.,
2016). In a separate report, phylogenetic and molecular clock
analyses performed on seven Brazilian ZIKV strains sug-
gested a single introduction of ZIKV into the Americas more
than 1 year before the first cases were detected in Brazil
(Faria et al., 2016). However, another study identified a slight
separation between Haitian and Brazilian strains, indicating
that ZIKV was circulating in Haiti as early as middle 2013,
before the first reported cases in Brazil (Lednicky et al.,
2016). Sequencing analysis also identified amino changes in
the outbreak lineage; however, no common substitutions
across the three currently available genomes from micro-
cephaly cases were apparent (Faria et al., 2016).
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Host–virus interactions that shape ZIKV infection remain
poorly characterized. Hamel et al. (2015) were the first to
show that human dermal fibroblasts, epidermal keratino-
cytes, and immature dendritic cells all were permissive to a
ZIKV isolate from French Polynesia. TLR3 was identified
as the initial immune receptor involved in the sensing of
ZIKV infection in human fibroblasts leading to type I and
type II interferon (IFN) responses (Hamel et al., 2015).
ZIKV also interacted with DC-SIGN to initiate infection of
immature Mo-DCs, whereas members of the TIM and TAM
family of phosphatidylserine receptors possibly serve as
receptors or attachment factors for other cells; in cutaneous
fibroblasts and epidermal keratinocytes lacking expression
of DC-SIGN, the TAM receptor AXL facilitated ZIKV entry
(Hamel et al., 2015).
Nowakowski et al. (2016) examined the receptor reper-
toire of human radial glia cells in the fetal brain involved in
ZIKV attachment and entry during neurogenesis. Distinct
flavivirus entry receptor genes, including AXL receptor,
were enriched in radial glia cells, astrocytes, endothelial
cells, and microglia, suggesting that these cell populations
may be particularly vulnerable to ZIKV infection in the
developing brain (Fig. 1). Both single-cell RNA-sequencing
and immunohistochemistry analyses confirmed high levels
of expression of the AXL receptor on radial glia cells
(Nowakowski et al., 2016); in contrast, other entry receptor
FIG. 1. ZIKV infection
mechanisms and neuropatho-
genesis. ZIKV is transmitted
via the bite of an infectedAedes
mosquito. (A) Both dermal fi-
broblasts and epidermal kera-
tinocytes are targets of ZIKV
infection, potentially transmit-
ting infection to dermal den-
dritic cells (Langerhans cell),
thereby facilitating ZIKV dis-
semination. (B) Transplacental
delivery of ZIKV to fetus may
occur by infection of cyto-
trophoblasts or transmigration
of infected primary human
placental macrophages (Hof-
bauer cells), suggesting a novel
mechanism for intrauterine
transmission. On ZIKV infec-
tion, Hofbauer placental mac-
rophages secrete type I IFN and
upregulate ISGs, although cells
remain permissive to ZIKV
replication. (C) At late stages
of pregnancy, the production of
IFNl1 and ISGs by placental
syncytiotrophoblasts may exert
protective effects inhibiting
ZIKV infection. (D) ZIKV di-
rectly targets neural progenitor
cells during the first trimester of
fetal brain development. The
TAM receptor AXL may have
an important role in ZIKV en-
try within neural cells. ZIKV-
dependent activation of TLR3-
mediated immune responses
leads to dysregulation of genes
involved in neuronal develop-
ment and apoptosis, resulting
in severe damage to the em-
bryonic brain, including mi-
crocephaly. ISGs, interferon
stimulated genes; ZIKV, Zika
virus. Figure illustrated by
David Olagnier using the Ser-
vier Medical Art library
(www.servier.fr/smart/banque-
dimages-powerpoint).
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candidates such as TYRO3 and DC-SIGN showed more
limited expression in the fetal brain.
While the characterization of AXL expression within cells
of the central nervous system (CNS) is a first step toward
defining ZIKV tropism, further studies are required to con-
firm whether AXL determines ZIKV tropism in neuronal
cells or in murine models in vivo, beyond its reported ability
to enhance attachment/entry in vitro in skin fibroblasts.
Efficient antagonism of the innate antiviral response is
crucial for flaviviruses that rely on viremia to maintain the
vector–host cycles. By analogy with dengue virus (DENV),
ZIKV infection resulted in the degradation of the IFN-
regulated transcriptional activator STAT2 in Vero cells, thus
inhibiting IFN-mediated induction of interferon stimulated
genes (ISGs) (Grant et al., 2016). Ectopic expression of the
nonstructural protein NS5 of ZIKV in HEK 293T cells was
sufficient to target STAT2 for proteasomal degradation.
DENV NS5 previously was demonstrated to bind STAT2 and
requires the E3 ubiquitin ligase UBR4 to promote STAT2
degradation (Ashour et al., 2009; Morrison et al., 2013). Like
DENV, ZIKV NS5 interacted with STAT2, although inde-
pendently of UBR4 (Grant et al., 2016). Interestingly, STAT2
levels were unaffected in ZIKV-infected primary mouse
embryonic fibroblasts and ZIKV replication was impaired,
suggesting that ZIKV IFN antagonism may be a species-
restricted mechanism (Grant et al., 2016).
Infection of Neural Progenitor Cells
ZIKV tropism extends to human neural progenitor cells
(hNPCs). Human-induced pluripotent stem cells differenti-
ate into forebrain-specific hNPCs and were infected effi-
ciently by the ZIKV prototype strain MR-766. ZIKV
infection also increased cell death and dysregulated cell
cycle progression, resulting in attenuated growth of cultured
stem cell-derived human cortical progenitors (Tang et al.,
2016); global gene expression analysis of infected hNPCs
further demonstrated transcriptional dysregulation of cell
cycle-related pathways. These results establish hNPCs, a
constitutive population of the developing embryonic brain,
as a target of ZIKV infection and injury, providing a first
clue to the neuropathology linked with microcephaly and
other CNS abnormalities (Tang et al., 2016).
Other studies have examined the effects of ZIKV infection
in human neural stem cells grown as neurospheres and brain
organoids (Dang et al., 2016; Garcez et al., 2016). Neuro-
spheres represent the very early stages of neurogenesis,
whereas brain organoid cultures recapitulate the early cellular
and molecular events of first-trimester fetal neocortex, in-
cluding gene expression and cortical layering (Lancaster
et al., 2013; Camp et al., 2015). ZIKV-infected hNPCs gen-
erated very few neurospheres, and those displayed morpho-
logical abnormalities and cell detachment, compared to the
hundreds of neurospheres detected under control conditions.
Apoptotic nuclei, as well as smooth membrane structures,
were observed in all ZIKV-infected neurospheres (Garcez
et al., 2016). These models mimic some features of first-
trimester brain development and suggest that ZIKV infection
during this time window may damage the developing brain.
Human embryonic stem cell-derived organoid cultures
were also used to investigate how ZIKV infection may lead
to microcephaly during the first trimester of fetal brain de-
velopment. Infection with the prototypical ZIKV MR-766
strain caused impaired development and severely inhibited
growth of cerebral organoids by activating TLR3-mediated
innate immune responses (Fig. 1). Interestingly, TLR3 in-
hibition reduced the phenotypic effects of ZIKV infection,
and a transcriptome profile of developing organoids re-
vealed dysregulation of a network of genes related to neu-
ronal development and apoptotic pathways following TLR3
stimulation (Dang et al., 2016). This study offers mechanistic
insight into the basis of microcephaly in ZIKV-infected
newborns.
Murine Models of ZIKV Pathogenesis
The establishment of murine models, and knowledge of
their strengths and limitations, will be extremely important
in the study of ZIKV pathogenesis, maternal-fetal trans-
mission, and development of vaccines and therapeutics
(Becker, 2016).
Because ZIKV is sensitive to the antiviral effects of
mouse type I and type II IFNs (Hamel et al., 2015), the
impact of ZIKV infection has been explored in IFN-
deficient murine models (Aliota et al., 2016; Dowall et al.,
2016; Lazear et al., 2016; Miner et al., 2016; Rossi et al.,
2016; Zmurko et al., 2016). Using different knockout
models and contemporary as well as historical ZIKV strains,
Lazear et al. (2016) demonstrated that 4- to 6-week-old
Irf3-/-Irf5-/-Irf7-/- triple knockout mice, which produce
little type I IFN, or mice lacking the IFN receptor (Ifnar1-/-)
developed neurological disease and succumbed to ZIKV
infection, whereas single Irf3-/-, Irf5-/-, or Mavs-/- knock-
out mice exhibited no overt illness. Ifnar1-/- mice sustained
high viral loads in the brain and spinal cord, consistent with
neurodevelopmental defects. The highest viral loads were
observed in the testes of Ifnar1-/- mice, an observation that
is relevant to sexual transmission of ZIKV (Lazear et al.,
2016). Also, a low-passage Cambodian isolate of ZIKV was
shown to cause disease and mortality in Ifnar-/- A129 mice
in an age-dependent manner (Rossi et al., 2016). Mice in-
fected at the youngest age (3 weeks) showed early viremia
at day 2; ZIKV was detected in the brain at day 3 and by day
6, signs of neurologic disease were observed. These animals
succumbed to illness by day 7, whereas in older mice (11
weeks), signs of illness, viremia, and weight loss were de-
tected, but the animals began to recover on day 8 (Rossi
et al., 2016). In another study, AG129 mice deficient in both
IFN-a/b and g receptors, succumbed to ZIKV infection within
7–8 days; rapid virus dissemination was observed in visceral
organs and the brain, but was associated with severe pathol-
ogy only in the brain and muscle (Aliota et al., 2016). Col-
lectively, these studies indicate that murine models of ZIKV
pathogenesis, although in immunocompromised strains, re-
capitulate some of the features of human neurological disease.
Importantly, ZIKV infection of the Ifnar1-/- mouse model
during pregnancy recapitulated features of placental tropism
and fetal demise associated with in utero transmission of ZIKV
(Miner et al., 2016). Ifnar1-/- female mice were crossed with
wild-type males and then inoculated with ZIKV on embryonic
day 6.5 or 7.5. ZIKV infected the pregnant dams, resulting in
damage to the placental barrier and infection of the developing
fetus, accompanied by trophoblast infection, placental insuffi-
ciency, and intrauterine growth restriction (Miner et al., 2016).
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Using contemporary ZIKV strains, vertical transmission
of ZIKV and a marked effect on fetal brain development
were characterized (Cugola et al., 2016; Li et al., 2016; Wu
et al., 2016). A Brazilian ZIKV strain (ZIKVBR) crossed the
placenta and caused microcephaly by targeting cortical
progenitor cells, causing cell death by apoptosis and au-
tophagy. Moreover, ZIKV infection impaired fetal neuro-
development and caused intrauterine growth restriction
(Cugola et al., 2016). Infection with a contemporary Asian
ZIKV strain (SZ01) led to cell cycle arrest, apoptosis, and
inhibition of NPC differentiation, thus disrupting neural
progenitor development in vivo and resulting in cortical
thinning and microcephaly in mice (Li et al., 2016). Infec-
tion of pregnant mice with ZIKV SZ01 led to the infection
of radial glia cells, with fetal mice exhibiting a reduced
cavity of lateral ventricles and a decrease in surface areas of
the cerebral cortex (Wu et al., 2016).
Together, these models provide a link between ZIKV
infection in neural cells and microcephaly, with potential for
further exploration of the underlying mechanisms.
Vertical Transmission and Transplacental Routes
of ZIKV Infection
The strong association between ZIKV infection in pregnant
women with the development of catastrophic neurodevelop-
mental outcomes suggests that ZIKV gains access to the in-
trauterine cavity directly to affect fetal development.
During mammalian pregnancy, the placenta acts as the sole
physical and immunological barrier between the maternal and
fetal compartments. Primary human trophoblasts (PHTs)
consist of both cytotrophoblasts and syncytiotrophoblasts that
are the key barrier cells, with syncytiotrophoblasts directly
bathed in maternal blood (Fig. 1). PHTs from term placentas
are refractory to ZIKV infection due to their constitutive re-
lease of antiviral IFNl1 (Bayer et al., 2016). In addition,
medium from uninfected PHT cells protected nonplacental
cells from ZIKV infection, and PHT cells themselves ex-
pressed high levels of ISGs, indicating that IFNl1 functions in
both paracrine and autocrine manners to protect trophoblast
and nontrophoblast cells (Bayer et al., 2016).
Trophoblast cell lines cultured from choriocarcinoma ex-
plants and first-trimester human villous explants, respectively,
were susceptible to ZIKV infection (Miner et al., 2016).
Conversely, placentas nearer to term, which form a more fully
developed placental barrier, exhibited greater resistance to
infection. To infect syncytiotrophoblasts, ZIKV likely must
evade the restriction imparted by trophoblast-derived IFNl1
and other trophoblast-specific antiviral factors (Delorme-
Axford et al., 2013) and/or gain access to the fetal compart-
ment using alternative strategies to cross the placental barrier,
at least in the second half of pregnancy, the gestational period
most represented by PHT cells. These pathways might include
nontrophoblast infectious routes, such as infection via im-
mune cells or transcytosis of virions complexed to maternal
immunoglobulins via the neonatal Fc receptor (FcRn).
Human placental macrophages (Hofbauer cells [HCs])
recently were described as permissive to ZIKV infection
(Quicke et al., 2016). These innate immune cells may rep-
resent key target cells in the placenta targeted by the virus
once it penetrates the trophoblast layer. On infection, HCs
produced IFN-a, proinflammatory cytokines, and activated
antiviral gene expression, although cell death was not sig-
nificantly induced (Fig. 1). Human placental cytotrophoblasts
also supported ZIKV replication, but with delayed replication
kinetics and ISG expression (Quicke et al., 2016). Thus,
studies to date point to a role for ZIKV replication within
cytotrophoblasts and HCs as a possible mechanism to facil-
itate vertical transmission. However, as syncytiotrophoblasts
are refractory to ZIKV infection (Bayer et al., 2016), the
mechanism(s) by which ZIKV accesses the underlying cy-
totrophoblast layer and HCs remains unknown. It is also im-
portant to note that the human placenta undergoes significant
morphological changes between the first and second half of
pregnancy, the most notable of which are the lack of maternal
blood contact with the syncytiotrophoblast layer in the first
trimester of pregnancy and the significant reduction in the
cytotrophoblast cellular layer as pregnancy progresses. Thus,
the mechanisms by which ZIKV is transmitted vertically may
be distinct at different gestational ages.
Summary and Perspectives
ZIKV infection of human embryonic NPCs provides a
potential mechanism for teratogenicity of ZIKV in the de-
veloping brain (Dang et al., 2016; Garcez et al., 2016; Tang
et al., 2016). These observations are consistent with studies
in mice demonstrating that high ZIKV loads in both brain
and spinal cord are associated with severe neuropathology
(Aliota et al., 2016; Lazear et al., 2016; Rossi et al., 2016)
and impairment of fetal brain development (Cugola et al.,
2016; Li et al., 2016; Wu et al., 2016). The latest in vivo
studies establish a direct causal link with microcephaly and
other abnormalities in the developing brain.
Despite a protective role of type III IFNl1 produced by
syncytiotrophoblasts of term placentas (Bayer et al., 2016),
fetal infection by ZIKV can occur by a transplacental route
in early pregnancy, resulting in infection of fetal brain,
placental damage, and fetal abortion (Cugola et al., 2016; Li
et al., 2016; Miner et al., 2016). However, studies also
suggest markedly different susceptibilities and/or distinct
mechanisms of pathogenesis at specific times during preg-
nancy (Bayer et al., 2016; Miner et al., 2016; Quicke et al.,
2016). It is possible that viremia in infected mothers, cou-
pled with blood-borne maternal transmission to the devel-
oping fetus, establishes a niche for virus growth that would
then facilitate neurological teratogenic effects. Once the
virus breaches the barrier presented by the trophoblasts, HCs
may become productively infected, thus facilitating vertical
transmission (Quicke et al., 2016).
As ZIKV research increasingly focuses on mechanisms of
neuropathogenesis, lessons learned from other flaviviruses
will undoubtedly facilitate a detailed mechanistic under-
standing of host–virus interactions, as well as contribute to
the development of novel therapeutics (Olagnier et al.,
2016). Critically important questions about ZIKV patho-
genesis have been addressed within a short frame of time,
but further work is urgently required to determine factors
that impact ZIKV infection, in utero transmission, and
neuropathogenic mechanisms (Fig. 1).
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